🇺🇸 FDA
Patent

US 9889209

Nanoconjugates able to cross the blood-brain barrier

granted A61KA61K47/6923A61K47/6929

Quick answer

US patent 9889209 (Nanoconjugates able to cross the blood-brain barrier) held by Northwestern University expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
38
CPC classes
A61K, A61K47/6923, A61K47/6929, A61K49/1851, A61P